Number of Shares
1.33 Mil
Current Holdings Value*
$44.56 Mil
% of Portfolio
4.39%
Total Estimate Gain
$-10.54 Mil
% of Total Estimate Gain
-18.01%

Affinity Asset Advisors, LLC's Xenon Pharmaceuticals Inc Holding Summary

As of 2025-03-31, Affinity Asset Advisors, LLC held 1.33 Mil shares of Xenon Pharmaceuticals Inc(XENE), totaling $44.56 Mil. This investment constitutes 4.39% of their stock portfolio, and Affinity Asset Advisors, LLC now holds 1.73% of the outstanding Xenon Pharmaceuticals Inc(XENE) stock.

The initial trade took place in 2021Q3. And since then Affinity Asset Advisors, LLC has made 11 purchases of XENE, at an average price of $38.80, for a total of 1.51 Mil shares. In addition, there have been 3 sales at an average price of $31.70 for 180,124.00 shares. Based on historical transaction data and XENE's current price of $31.83, Affinity Asset Advisors, LLC's estimated gain on his XENE holdings is $-10.54 Mil, reflecting a -18.01% gain to date.

Affinity Asset Advisors, LLC XENE ($31.83) Holding Chart

Affinity Asset Advisors, LLC XENE ($31.83) Quarterly Buys and Sells

Period Bought/Sold (Sh.) % Change Qtr. End Shares Avrg. Price
Shares Bought 0 Average Price $-/Share
Shares Sold 0 Average Price $-/Share
Current Price $0.00 Total Estimated Gain 0 %

Top Ranked Articles

  • 1